GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adverum Biotechnologies Inc (LTS:0HA3) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Adverum Biotechnologies (LTS:0HA3) Future 3-5Y EPS without NRI Growth Rate : 25.63 (As of Sep. 23, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Adverum Biotechnologies Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Adverum Biotechnologies's Future 3-5Y EPS without NRI Growth Rate is 25.63.


Competitive Comparison of Adverum Biotechnologies's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Adverum Biotechnologies's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adverum Biotechnologies's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adverum Biotechnologies's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Adverum Biotechnologies's Future 3-5Y EPS without NRI Growth Rate falls into.



Adverum Biotechnologies  (LTS:0HA3) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Adverum Biotechnologies Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Adverum Biotechnologies's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Adverum Biotechnologies Business Description

Industry
Traded in Other Exchanges
Address
100 Cardinal Way, Redwood CIty, CA, USA, 94063
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Adverum Biotechnologies Headlines

No Headlines